REPATHA AUTOINJECTOR 140 MG / SYR INJECTION SYRINGE
284.8300 SYR
AMG
N/A
N/A
NO
SPECIAL AUTHORIZATION
Details
02459779
EVOLOCUMAB
REPATHA 420 MG INJECTION CARTRIDGE
587.7500 CTG
AMG
N/A
N/A
NO
SPECIAL AUTHORIZATION
Details
DIN/NPN/ PIN
02453835
Generic Name
ALIROCUMAB
Product Name, Strength & Dosage Form
PRALUENT 150 MG / ML INJECTION
Unit Price, Unit of Issue
267.8300
Manufacturer
SAV
LCA Price
N/A
MAC Price
N/A
Interchangeable Products
NO
Coverage Status
SPECIAL AUTHORIZATION
Details
DIN/NPN/ PIN
02453819
Generic Name
ALIROCUMAB
Product Name, Strength & Dosage Form
PRALUENT 75 MG / ML INJECTION
Unit Price, Unit of Issue
267.8300
Manufacturer
SAV
LCA Price
N/A
MAC Price
N/A
Interchangeable Products
NO
Coverage Status
SPECIAL AUTHORIZATION
Details
DIN/NPN/ PIN
02446057
Generic Name
EVOLOCUMAB
Product Name, Strength & Dosage Form
REPATHA AUTOINJECTOR 140 MG / SYR INJECTION SYRINGE
Unit Price, Unit of Issue
284.8300
Manufacturer
AMG
LCA Price
N/A
MAC Price
N/A
Interchangeable Products
NO
Coverage Status
SPECIAL AUTHORIZATION
Details
DIN/NPN/ PIN
02459779
Generic Name
EVOLOCUMAB
Product Name, Strength & Dosage Form
REPATHA 420 MG INJECTION CARTRIDGE
Unit Price, Unit of Issue
587.7500
Manufacturer
AMG
LCA Price
N/A
MAC Price
N/A
Interchangeable Products
NO
Coverage Status
SPECIAL AUTHORIZATION
Details
Telephone:
Toll-Free:
To return to the printable Drug Benefit List and related publications,
click here
Last Updated:
NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.
Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.
Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.